---
figid: PMC5923345__cancers-10-00090-g001
figtitle: NF2/merlin-Hippo signaling cascade dysregulation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5923345
filename: cancers-10-00090-g001.jpg
figlink: /pmc/articles/PMC5923345/figure/cancers-10-00090-f001/
number: F1
caption: 'Schematic representation showing NF2/merlin-Hippo signaling cascade dysregulation
  in malignant mesothelioma (MM) cells. Signals from the extracellular environment,
  transduced via cell-cell contact (cadherin), cell-matrix contact (CD44 and integrin),
  and/or growth factor receptors (receptor tyrosine kinases, RTKs), affect merlin
  tumor-suppressive activity. Activated (underphosphorylated) merlin regulates the
  Hippo signaling cascade and suppresses the activity of the YAP1/TAZ transcriptional
  coactivators. As MMs show frequent alteration of merlin (the NF2 gene product) and
  Hippo pathway components including LATS1/2, the resultant underphosphorylated (activated)
  YAP1/TAZ transcriptional coactivators enhance the expression of many pro-oncogenic
  genes including CCDN1, FOXM1, CTGF, and PLCB4 in MM cells. P: phosphorylation, Ub:
  ubiquitination.'
papertitle: Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for
  Malignant Mesothelioma.
reftext: Yoshitaka Sekido. Cancers (Basel). 2018 Apr;10(4):90.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9617484
figid_alias: PMC5923345__F1
figtype: Figure
redirect_from: /figures/PMC5923345__F1
ndex: 78861b22-dedb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5923345__cancers-10-00090-g001.html
  '@type': Dataset
  description: 'Schematic representation showing NF2/merlin-Hippo signaling cascade
    dysregulation in malignant mesothelioma (MM) cells. Signals from the extracellular
    environment, transduced via cell-cell contact (cadherin), cell-matrix contact
    (CD44 and integrin), and/or growth factor receptors (receptor tyrosine kinases,
    RTKs), affect merlin tumor-suppressive activity. Activated (underphosphorylated)
    merlin regulates the Hippo signaling cascade and suppresses the activity of the
    YAP1/TAZ transcriptional coactivators. As MMs show frequent alteration of merlin
    (the NF2 gene product) and Hippo pathway components including LATS1/2, the resultant
    underphosphorylated (activated) YAP1/TAZ transcriptional coactivators enhance
    the expression of many pro-oncogenic genes including CCDN1, FOXM1, CTGF, and PLCB4
    in MM cells. P: phosphorylation, Ub: ubiquitination.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD44
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - ACAT1
  - CES1
  - SOAT1
  - PTK2
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - LIN28B
  - BCAT1
  - BCAT2
  - MST1
  - STK4
  - STK3
  - NF2
  - MYC
  - KRAS
  - HRAS
  - NRAS
  - SAV1
  - AJUBA
  - CXCL10
  - MOB4
  - MOB1A
  - SGMS1
  - MOB1B
  - LATS1
  - LATS2
  - TAFAZZIN
  - WWTR1
  - YAP1
  - VGLL4
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - CCND1
  - FOXM1
  - PLCB4
  - CCN2
  - AMOT
  - PLCB4
  - Cancer
wpid: WP4541
---
